Rigel ( (RIGL)) has provided an announcement. On December 7, 2025, Rigel Pharmaceuticals announced updated data from its ongoing Phase 1b study of R289, an oral prodrug, in patients with relapsed or ...
Don't miss 'The Curse of Rigel ' Expansion Launch Trailer for Wartales, an open-world turn-based strategy RPG developed by Shiro Games. Players will enforce the King's will to venture into the County ...
Toronto, Ontario--(Newsfile Corp. - December 16, 2025) - Rigel Technologies Inc. (the "Company") is pleased to announce it has entered into a non-binding letter of intent (the "LOI"), dated December ...
Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...
2-Year U.S. Treasury Note Continuous Contract $104.387 0.016 0.01% 5-Year U.S. Treasury Note Continuous Contract $109.281 0.039 0.04% 10-Year U.S. Treasury Note Continuous Contract $112.391 0.063 0.06 ...
Mini's EV lineup in North America is currently limited to only the Countryman Electric SUV, but the smaller Aceman crossover had been planned to launch here. Sadly, it's been cancelled due to tariffs ...
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Challenge yourself every day with a free mini version of the classic crossword puzzle. Can you solve The Mini in minutes — or seconds? Play a new puzzle every day or browse the archive. Jump in to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback